Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How to stop a stroke in its tracks

  • Significant increase in major depression reported during recent recession

  • Discovery may open door for treating fragile X carriers

  • Fat tissue controls brain's response to food scarcity, helping regulate optimal amount of body fat for brain function

  • Risk perception: Social exchange can amplify subjective fears

  • Psychology of the appeal of being anti-GMO

  • New light shed on brain's source of power

  • We think better on our feet, literally

  • Inclusive classrooms don't necessarily increase friendships for children with disabilities

  • New insight into how brain makes memories

  •